To evaluate the targeted delivery and therapeutic efficacy of ICAM1‐AFM41a‐AuNPs nanodrug in a PA‐induced ALI model, we conducted an in vivo experiment as outlined in Figure7A. This evidence concerns the gene ICAM1 and acute respiratory distress syndrome.